A single-dose ascending study and a multiple-dose study in healthy male subjects and a multiple-dose study in subjects who have no more than 3 spontaneous bowel movements per week to investigate the tolerability, safety, pharmacokinetics, and pharmacodynamics of DSP-6952, and a single-dose study in healthy male subjects to examine the effect of food
Latest Information Update: 07 Dec 2021
At a glance
- Drugs Minesapride (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Adverse reactions
- Sponsors Sumitomo Dainippon Pharma
- 22 Nov 2017 Status changed from active, no longer recruiting to completed.
- 22 Feb 2012 New trial record